Andrx' Concerta Generic Likely Blocked By Another ANDA Filer's Exclusivity
J&J recently listed a new patent for Concerta, and another generic company appears to hold 180-day exclusivity based on that patent, Andrx says.
J&J recently listed a new patent for Concerta, and another generic company appears to hold 180-day exclusivity based on that patent, Andrx says.